Investing.com - Liminal BioSciences Inc reported on Wednesday third quarter earnings that missed analysts' forecasts and revenue that fell short of expectations.
Liminal BioSciences Inc announced earnings per share of C$-0.150 on revenue of C$3K. Analysts polled by Investing.com anticipated EPS of C$-0.140 on revenue of C$1.09M.
Liminal BioSciences Inc shares are down 29.95% from the beginning of the year and are trading at C$0.495 , down-from-52-week-high.
Liminal BioSciences Inc follows other major Healthcare sector earnings this month
Liminal BioSciences Inc's report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of C$5.79 on revenue of C$80.89B, compared to forecasts EPS of C$5.43 on revenue of C$80.52B.
J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of C$2.55 on revenue of C$23.79B, compared to forecast for EPS of C$2.52 on revenue of C$23.46B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar